Share Price, page-45

Hi Wasa,

Obviously the range of possibilities here is vast.

Failure of Rett's P3 would see the value of the company plummet, but we do have the relative luxury of 2591 being funded to carry out the 4 P2 trials and therefore still a (much delayed) possibility of a bright financial future.

Success in Rett's will probably see our SP hit an all time high with further Trof value determined as subsequent events unfold. In addition, 2591's value would be enhanced.

To put it simply, we could end up in the toilet, or amongst the stars - not strange really as we are still a speculative company, with all the attendant risks and potential rewards still in play.

On the positive side, long term holders will be given the opportunity to choose between a decent profit or to continue to chance their arm with further speculation as the r&d continues.

On the negative side, the choice will be to get out at some sort of loss or to persevere with 2591.

All in all, we are still (and will be for some time) in the glorious uncertainty of speculative investing.

Of course a takeover (which would indicate some sort of success from here) would bring all the speculation to an abrupt end at some time along journey.